IncantheraAQSE:INC Gross Margin % is 83.33% as of Sep. 2025. The stock has 2 warning signs investors should review. Among 732 Biotechnology companies, Incanthera ranks better than 76.09% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Incanthera's Gross Profit for the
six
months ended in Sep. 2025 was £0.01 Mil. Incanthera's Revenue for the
six
months ended in Sep. 2025 was £0.01 Mil. Therefore, Incanthera's Gross Margin % for the quarter that ended in Sep. 2025 was 83.33%.
The historical rank and industry rank for Incanthera's Gross Margin % or its related term are showing as below:
AQSE:INC'
s Gross Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 83.33
Current: 83.33
During the past 6 years, the highestGross Margin % of Incanthera was 83.33%. The lowest was 0.00%. And the median was 0.00%.
AQSE:INC's Gross Margin % is ranked better than 76.09% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs AQSE:INC: 83.33
Incanthera had a gross margin of 83.33% for the quarter that ended in Sep. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Incanthera was 0.00% per year.
Incanthera (AQSE:INC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Incanthera had a gross margin of 83.33% for the quarter that ended in Sep. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Incanthera Gross Margin % Related Terms
Incanthera Gross Margin % Historical Data
* Premium members only.
The historical data trend for Incanthera's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:INC vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Incanthera's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Incanthera Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Incanthera's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Incanthera's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Incanthera (AQSE:INC) has a Gross Margin % of 83.33% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Incanthera and its competitors. According to the industry distribution chart, Incanthera ranks #175 out of 732 companies in the Biotechnology industry, placing it in the top 23.9%.
Is Incanthera's Gross Margin % too high?
Incanthera's current Gross Margin % is 83.33%. The Biotechnology industry median Gross Margin % is 60.91. Incanthera's value of 83.33% is 36.8% above this industry median. Based on the distribution chart, Incanthera ranks #175 out of 732 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Incanthera's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Incanthera ranks #175 out of 732 companies for Gross Margin %. This places Incanthera in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.91. Incanthera's value of 83.33% is 36.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Incanthera's current Gross Margin % of 83.33% is 36.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Incanthera and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Incanthera's current Gross Margin % is 83.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incanthera stock overvalued right now?
Incanthera (AQSE:INC) has a current Gross Margin % of 83.33%. The current Gross Margin % is 83.33% and 36.8% above the Biotechnology industry median of 60.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Incanthera (AQSE:INC), the current Gross Margin % is 83.33% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Incanthera PLC is clinical stage drug development. It specializes in dermatology and oncology therapeutics. The company has launched a skincare range called Skin + CELL, which addresses and enhances life quality through effective delivery of bioactive ingredients capable of energising the skin's natural repair and defence processes at the cellular level. It has one reportable segment, namely the development of dermatology and pharmaceutical products, within the United Kingdom and Switzerland.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:INC has been successfully added to your 